REPORT ID 836

Global Viral Vector Development Service Market Size, Status and Forecast 2022

Publish Date
04-Dec-17
Pages
104
Format
Electronic (PDF)

This report studies the global Viral Vector Development Service market, analyzes and researches the Viral Vector Development Service development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Kaneka Eurogentec
    FinVector
    Brammer Bio
    Cell and Gene Therapy Catapult
    FUJIFILM Diosynth Biotechnologies
    Sanofi
    Spark Therapeutics
    Cobra Biologics
    UniQure and MassBiologics
    Renova Therapeutics
    Shenzhen SiBiono GeneTech
    Thermo Fisher Scientific

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Retroviral Vectors
    Lentiviral Vectors
    Adenoviral Vectors
    Adeno-associated Viral Vectors
    Other Viral Vectors

Market segment by Application, Viral Vector Development Service can be split into
    Pharmaceutical Manufacturers
    Biotechnology Companies
    Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Viral Vector Development Service Market Size, Status and Forecast 2022
1 Industry Overview of Viral Vector Development Service
    1.1  Viral Vector Development Service Market Overview
        1.1.1 Viral Vector Development Service Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Viral Vector Development Service Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Viral Vector Development Service Market by Type
        1.3.1 Retroviral Vectors
        1.3.2 Lentiviral Vectors
        1.3.3 Adenoviral Vectors
        1.3.4 Adeno-associated Viral Vectors
        1.3.5 Other Viral Vectors
    1.4 Viral Vector Development Service Market by End Users/Application
        1.4.1 Pharmaceutical Manufacturers
        1.4.2 Biotechnology Companies
        1.4.3 Research Institutes

2 Global Viral Vector Development Service Competition Analysis by Players
    2.1 Viral Vector Development Service Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Kaneka Eurogentec
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 FinVector
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Brammer Bio
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Cell and Gene Therapy Catapult
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 FUJIFILM Diosynth Biotechnologies
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Sanofi
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Spark Therapeutics
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Cobra Biologics
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 UniQure and MassBiologics
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Renova Therapeutics
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Viral Vector Development Service Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Shenzhen SiBiono GeneTech
    3.12 Thermo Fisher Scientific

4 Global Viral Vector Development Service Market Size by Type and Application (2012-2017)
    4.1 Global Viral Vector Development Service Market Size by Type (2012-2017)
    4.2 Global Viral Vector Development Service Market Size by Application (2012-2017)
    4.3 Potential Application of Viral Vector Development Service in Future
    4.4 Top Consumer/End Users of Viral Vector Development Service

5 United States Viral Vector Development Service Development Status and Outlook
    5.1 United States Viral Vector Development Service Market Size (2012-2017)
    5.2 United States Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

6 EU Viral Vector Development Service Development Status and Outlook
    6.1 EU Viral Vector Development Service Market Size (2012-2017)
    6.2 EU Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

7 Japan Viral Vector Development Service Development Status and Outlook
    7.1 Japan Viral Vector Development Service Market Size (2012-2017)
    7.2 Japan Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

8 China Viral Vector Development Service Development Status and Outlook
    8.1 China Viral Vector Development Service Market Size (2012-2017)
    8.2 China Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

9 India Viral Vector Development Service Development Status and Outlook
    9.1 India Viral Vector Development Service Market Size (2012-2017)
    9.2 India Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Viral Vector Development Service Development Status and Outlook
    10.1 Southeast Asia Viral Vector Development Service Market Size (2012-2017)
    10.2 Southeast Asia Viral Vector Development Service Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Viral Vector Development Service Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Viral Vector Development Service Revenue and Growth Rate (2017-2022)
        11.1.2 EU Viral Vector Development Service Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Viral Vector Development Service Revenue and Growth Rate (2017-2022)
        11.1.4 China Viral Vector Development Service Revenue and Growth Rate (2017-2022)
        11.1.5 India Viral Vector Development Service Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Viral Vector Development Service Revenue and Growth Rate (2017-2022)
    11.2 Global Viral Vector Development Service Market Size (Value) by Type (2017-2022)
    11.3 Global Viral Vector Development Service Market Size by Application (2017-2022)

12 Viral Vector Development Service Market Dynamics
    12.1 Viral Vector Development Service Market Opportunities
    12.2 Viral Vector Development Service Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Viral Vector Development Service Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Viral Vector Development Service Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source